Join Ingredion for an exclusive, in-person breakfast briefing, delivered in partnership with NielsenIQ (NIQ), bringing together consumer intelligence, AI-driven innovation, and product inspiration to help brands navigate this new moment with confidence.
GLP-1 medications are rapidly reshaping how consumers eat, shop, and engage with food. For FMCG organisations across Australia and New Zealand, this shift is already influencing category performance, innovation pipelines and formulation strategy.
Seats are limited — RSVP via the link below to secure your place.
Breakfast Event RSVP
Agenda highlights
- GLP-1 impact across Australia & New Zealand — how consumption and category dynamics are shifting
- How FMCG companies can adapt formulation strategies to address the GLP-1 market
- AI-driven flavour discovery
- Partner led product creation: from insight to prototype
- AI testing and optimisation
- Key learnings for future FMCG innovation
- Networking breakfast — connect with peers across FMCG, innovation, insights and R&D
Speakers
Kemilyn Ferraz
Category Marketing Executive | Ingredion
Kemilyn leads category marketing at Ingredion, partnering with FMCG customers across Australia and New Zealand to translate consumer insights, category trends and ingredient capabilities into commercially relevant innovation. Her work focuses on helping brands respond to emerging moments — such as GLP-1 — through smarter formulation, renovation and product development strategies.
Roopam Bahl
Director, Innovation Research – Pacific | NIQ BASES
Roopam Bahl leads innovation research for the Pacific at NIQ BASES, with deep expertise at the intersection of product innovation, consumer research, and AI. She works closely with FMCG, retail and technology teams to embed AI across the product lifecycle — helping organisations move faster while staying grounded in real consumer understanding.